Nature Communications (Jan 2025)
Author Correction: Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19
- Yongzhi Lu,
- Qi Yang,
- Ting Ran,
- Guihua Zhang,
- Wenqi Li,
- Peiqi Zhou,
- Jielin Tang,
- Minxian Dai,
- Jinpeng Zhong,
- Hua Chen,
- Pan He,
- Anqi Zhou,
- Bao Xue,
- Jiayi Chen,
- Jiyun Zhang,
- Sidi Yang,
- Kunzhong Wu,
- Xinyu Wu,
- Miru Tang,
- Wei K. Zhang,
- Deyin Guo,
- Xinwen Chen,
- Hongming Chen,
- Jinsai Shang
Affiliations
- Yongzhi Lu
- Guangzhou National Laboratory
- Qi Yang
- Guangzhou National Laboratory
- Ting Ran
- Guangzhou National Laboratory
- Guihua Zhang
- Guangzhou National Laboratory
- Wenqi Li
- Guangzhou National Laboratory
- Peiqi Zhou
- Guangzhou National Laboratory
- Jielin Tang
- Guangzhou National Laboratory
- Minxian Dai
- Guangzhou National Laboratory
- Jinpeng Zhong
- Guangzhou National Laboratory
- Hua Chen
- Guangzhou National Laboratory
- Pan He
- Guangzhou National Laboratory
- Anqi Zhou
- School of Basic Medical Sciences, Guangzhou Laboratory, Guangzhou Medical University
- Bao Xue
- Guangzhou National Laboratory
- Jiayi Chen
- Guangzhou National Laboratory
- Jiyun Zhang
- Guangzhou National Laboratory
- Sidi Yang
- Guangzhou National Laboratory
- Kunzhong Wu
- Guangzhou National Laboratory
- Xinyu Wu
- Guangzhou National Laboratory
- Miru Tang
- Guangzhou National Laboratory
- Wei K. Zhang
- Guangzhou National Laboratory
- Deyin Guo
- Guangzhou National Laboratory
- Xinwen Chen
- Guangzhou National Laboratory
- Hongming Chen
- Guangzhou National Laboratory
- Jinsai Shang
- Guangzhou National Laboratory
- DOI
- https://doi.org/10.1038/s41467-025-56341-8
- Journal volume & issue
-
Vol. 16,
no. 1
pp. 1 – 1
Abstract
No abstracts available.
